Cost-Effectiveness of Rivaroxaban and Aspirin Compared to Aspirin Alone in Patients with Stable Cardiovascular Disease- An Australian Perspective
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.013
https://www.valueinhealthjournal.com/article/S1098-3015(18)32369-6/fulltext
Title :
Cost-Effectiveness of Rivaroxaban and Aspirin Compared to Aspirin Alone in Patients with Stable Cardiovascular Disease- An Australian Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32369-6&doi=10.1016/j.jval.2018.07.013
First page :
Section Title :
Open access? :
No
Section Order :
149